Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial

被引:104
作者
Smith, GD
Bracha, Y
Svendsen, KH
Neaton, JD
Haffner, SM
Kuller, LH
机构
[1] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
[2] Minneapolis Med Res Fdn Inc, Minneapolis, MN USA
[3] Univ Minnesota, Minneapolis, MN USA
[4] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[5] Univ Pittsburgh, Pittsburgh, PA USA
关键词
D O I
10.7326/0003-4819-142-5-200503010-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: weight loss and increased physical exercise reduce the risk for diabetes in people with impaired glucose tolerance. Randomized trial evidence on the effect of these interventions on people without impaired glucose tolerance is lacking. Objective: To examine the influence of a comprehensive intervention program on the risk for developing diabetes in men without impaired glucose tolerance and in a post hoc subgroup analysis by baseline cigarette smoking status. Design: Randomized, controlled trial. Setting: 22 clinical centers for the Multiple Risk Factor Intervention Trial (MRFIT). Participants: 12 866 men age 35 to 57 years at risk for cardiovascular disease were randomly assigned to either a special intervention or usual care group and followed for 6 to 7 years; this report focuses on 11 827 men without diabetes or impaired glucose tolerance at entry for whom follow-up glucose measurements were available. Measurements: Cardiovascular disease risk factors, fasting blood glucose levels, and diabetes medication history were assessed before randomization and annually. Intervention: Men in the special intervention group were counseled to change diet (reduce saturated fat, cholesterol, and calorie intake), to stop smoking, and to increase physical activity. Blood pressure was treated more intensively in the special intervention group than in the usual care group. Results: 11.5% of the special intervention group and 10.8% of the usual care group developed diabetes over 6 years of follow-up (hazard ratio, 1.08 [95% Cl, 0.96 to 1.20]). The special intervention-usual care hazard ratio for diabetes was 1.26 (Cl, 1.10 to 1.45) among smokers (63%) and 0.82 (Cl, 0.68 to 0.98) among nonsmokers (37%). These estimates differed significantly (P = 0.0003). Weight gain after smoking cessation and the use of anti hypertensive drugs may have counterbalanced the beneficial effect of the lifestyle intervention for the special intervention group smokers, while the lifestyle intervention was beneficial among nonsmokers. Conclusions: In nonsmokers, an intervention program that included nutrition counseling to produce reductions in weight, serum cholesterol, and (along with anti hypertensive medication) blood pressure reduced the risk for diabetes.
引用
收藏
页码:313 / 322
页数:10
相关论文
共 52 条
[32]   THE INFLUENCE OF BODY-FAT DISTRIBUTION ON THE INCIDENCE OF DIABETES-MELLITUS - 13.5 YEARS OF FOLLOW-UP OF THE PARTICIPANTS IN THE STUDY OF MEN BORN IN 1913 [J].
OHLSON, LO ;
LARSSON, B ;
SVARDSUDD, K ;
WELIN, L ;
ERIKSSON, H ;
WILHELMSEN, L ;
BJORNTORP, P ;
TIBBLIN, G .
DIABETES, 1985, 34 (10) :1055-1058
[33]  
PAGE RCL, 1993, Q J MED, V86, P145
[34]   ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE [J].
REAVEN, GM .
DIABETES, 1988, 37 (12) :1595-1607
[35]   PROSPECTIVE-STUDY OF CIGARETTE-SMOKING, ALCOHOL-USE, AND THE RISK OF DIABETES IN MEN [J].
RIMM, EB ;
CHAN, J ;
STAMPFER, MJ ;
COLDITZ, GA ;
WILLETT, WC .
BRITISH MEDICAL JOURNAL, 1995, 310 (6979) :555-559
[36]  
ROBERTS J, 1966, VITAL HLTH STAT SERI
[37]   10-YEAR FOLLOW-UP OF SUBJECTS WITH IMPAIRED GLUCOSE-TOLERANCE - PREVENTION OF DIABETES BY TOLBUTAMIDE AND DIET REGULATION [J].
SARTOR, G ;
SCHERSTEN, B ;
CARLSTROM, S ;
MELANDER, A ;
NORDEN, A ;
PERSSON, G .
DIABETES, 1980, 29 (01) :41-49
[38]   RISK-FACTORS FOR THE DEVELOPMENT OF TYPE-II DIABETES AMONG MEN ENROLLED IN THE USUAL CARE GROUP OF THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].
SHATEN, BJ ;
SMITH, GD ;
KULLER, LH ;
NEATON, JD .
DIABETES CARE, 1993, 16 (10) :1331-1339
[39]   THE MULTIPLE RISK FACTOR INTERVENTION TRIAL (MRFIT) .2. THE DEVELOPMENT OF THE PROTOCOL [J].
SHERWIN, R ;
KAELBER, CT ;
KEZDI, P ;
KJELSBERG, MO ;
THOMAS, HE .
PREVENTIVE MEDICINE, 1981, 10 (04) :402-425
[40]  
SHINTANI TT, 1991, AM J CLIN NUTR, V53, pS1647